Cargando…
Ten-year survival of pancreas cancer with liver metastases treated by intraoperative and long-term intraperitoneal gemcitabine. A case report
INTRODUCTION AND IMPORTANCE: Progress in the management of pancreas cancer has been slow to occur. Resection of the primary cancer in the head of the pancreas is possible and has become a standard of care in operable patients. Unfortunately, long-term survival after this extensive surgical procedure...
Autores principales: | Sugarbaker, Paul H., Steves, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209121/ https://www.ncbi.nlm.nih.gov/pubmed/37209455 http://dx.doi.org/10.1016/j.ijscr.2023.108313 |
Ejemplares similares
-
Twenty-year survival of gastric cancer with peritoneal metastases using long-term normothermic intraperitoneal 5-fluorouracil and systemic mitomycin C: A case report
por: Sugarbaker, Paul H.
Publicado: (2019) -
Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data
por: Sugarbaker, Paul H., et al.
Publicado: (2011) -
Pancreas Cancer Survival in the Gemcitabine Era
por: Wachtel, Mitchell S., et al.
Publicado: (2008) -
Effects of Deep Hyperthermia Combined with Intraperitoneal Chemotherapy on Liver-Kidney Function, Immune Function, and Long-Term Survival in Patients with Abdominal Metastases
por: Zhang, Yan, et al.
Publicado: (2023) -
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
por: Stintzing, Sebastian, et al.
Publicado: (2019)